Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: A nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study

Menopause

Volumn 22, Issue 4, 2015, Pages 384-390

  Gentry Maharaj, Aleksandra ^a   Karpinskyj, Chloe ^a   Glazer, Clara ^a   Burnell, Matthew ^a   Ryan, Andy ^a   Fraser, Lindsay ^a   Lanceley, Anne ^a   Jacobs, Ian ^a,b   Hunter, Myra S ^c   Menon, Usha ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Complementary and alternative medicines; Hormone therapy; Menopause; United Kingdom Collaborative Trial of Ovarian Cancer Screening; Vasomotor symptoms

Indexed keywords

ANTIHYPERTENSIVE AGENT; FLUOXETINE; GESTAGEN; MEGESTROL; PRIMROSE OIL; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ACTAEA RACEMOSA; ADULT; ALTERNATIVE MEDICINE; ARTICLE; CLIMACTERIUM; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE SURVEY; HORMONAL THERAPY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; OVARY CANCER; POSTMENOPAUSE; PREVALENCE; QUALITY OF LIFE; UNITED KINGDOM; WELLBEING; WOMEN'S HEALTH; AGED; CASE CONTROL STUDY; EXERCISE; HERBAL MEDICINE; HORMONE SUBSTITUTION; HOT FLASHES; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; QUESTIONNAIRE; SWEATING; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

AGED; CASE-CONTROL STUDIES; COMPLEMENTARY THERAPIES; EXERCISE; FEMALE; HERBAL MEDICINE; HORMONE REPLACEMENT THERAPY; HOT FLASHES; HUMANS; MIDDLE AGED; SURVEYS AND QUESTIONNAIRES; SWEATING; TREATMENT OUTCOME; UNITED KINGDOM; WITHHOLDING TREATMENT;

EID: 84926650656     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000330     Document Type: Article

References (35)

1. Mishra GD, Kuh D,. Health symptoms during midlife in relation to menopausal transition: British prospective cohort study. BMJ 2012; 344: e402
2. Palacios S, Henderson VW, Siseles N, Tan D, Villaseca P,. Age of menopause and impact of climacteric symptoms by geographical region. Climacteric 2010; 13: 419-428
3. Moilanen J, Aalto AM, Hemminki E, Aro AR, Raitanen J, Luoto R,. Prevalence of menopause symptoms and their association with lifestyle among Finnish middle-Aged women. Maturitas 2010; 67: 368-374
4. Politi MC, Schleinitz MD, Col NF,. Revisiting the duration of vasomotor symptoms of menopause: a meta-Analysis. J Gen Intern Med 2008; 23: 1507-1513
5. Daly E, Gray A, Barlow D, McPherson K, Roche M, Vessey M,. Measuring the impact of menopausal symptoms on quality of life. BMJ 1993; 307: 836-840
6. Maclennan AH, Broadbent JL, Lester S, Moore V,. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2004; CD002978
7. Welton AJ, Vickers MR, Kim J, Health related quality of life after combined hormone replacement therapy: randomised controlled trial. BMJ 2008; 337: a1190
8. Menon U, Burnell M, Sharma A, Decline in use of hormone therapy among postmenopausal women in the United Kingdom. Menopause 2007; 14 (pt 1): 462-467
9. Rossouw JE, Anderson GL, Prentice RL, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333
10. Borrelli F, Ernst E,. Alternative and complementary therapies for the menopause. Maturitas 2010; 66: 333-343
11. National Center for Complementary and Alternative Medicine at the National Institutes of Health. Complementary, alternative, or integrative health: what's in a name? Available at: http://nccam.nih.gov/health/whatiscam/ Accessed July 3, 2014
12. Leach MJ, Moore V,. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev 2012; 9: CD007244
13. Menon U, Gentry-Maharaj A, Ryan A, Recruitment to multicentre trials-lessons from UKCTOCS: descriptive study. BMJ 2008; 337: a2079
14. Sternfeld B, Guthrie KA, Ensrud KE, Efficacy of exercise for menopausal symptoms: a randomized controlled trial. Menopause 2014; 21: 330-338
15. Daley A, Stokes-Lampard H, MacArthur C,. Exercise for vasomotor menopausal symptoms. Cochrane Database Syst Rev 2011; CD006108
16. Hunter MS, Gentry-Maharaj A, Ryan A, Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10,418 British women aged 54-65. BJOG 2012; 119: 40-50
17. Kupferer EM, Dormire SL, Becker H,. Complementary and alternative medicine use for vasomotor symptoms among women who have discontinued hormone therapy. J Obstet Gynecol Neonatal Nurs 2009; 38: 50-59
18. The Million Women Study Collaborative Group. The Million Women Study: design and characteristics of the study population. The Million Women Study Collaborative Group. Breast Cancer Res 1999; 1: 73-80
19. Espen Gjelsvik B, Straand J, Hunskaar S, Dalen I, Rosvold EO,. Use and discontinued use of menopausal hormone therapy by healthy women in Norway: the Hordaland Women's Cohort study. Menopause 2014; 21: 459-468
20. Panay N, Hamoda H, Arya R, Savvas M,. The 2013 British Menopause Society & Women's Health Concern recommendations on hormone replacement therapy. Menopause Int 2013; 19: 59-68
21. Posadzki P, Lee MS, Moon TW, Choi TY, Park TY, Ernst E,. Prevalence of complementary and alternative medicine (CAM) use by menopausal women: a systematic review of surveys. Maturitas 2013; 75: 34-43
22. Reed SD, Guthrie KA, Newton KM, Menopausal quality of life: RCT of yoga, exercise, and ω-3 supplements. Am J Obstet Gynecol 2014; 210: 244.e1-244.e11
23. Carmody JF, Crawford S, Salmoirago-Blotcher E, Leung K, Churchill L, Olendzki N,. Mindfulness training for coping with hot flashes: results of a randomized trial. Menopause 2011; 18: 611-620
24. Herber-Gast GC, Mishra GD,. Fruit, Mediterranean-style, and high-fat and-sugar diets are associated with the risk of night sweats and hot flushes in midlife: results from a prospective cohort study. Am J Clin Nutr 2013; 97: 1092-1099
25. Tremblay A, Sheeran L, Aranda SK,. Psychoeducational interventions to alleviate hot flashes: a systematic review. Menopause 2008; 15: 193-202
26. Ayers B, Smith M, Hellier J, Mann E, Hunter MS,. Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial. Menopause 2012; 19: 749-759
27. Stefanopoulou E, Hunter MS,. Telephone-guided Self-Help Cognitive Behavioural Therapy for menopausal symptoms. Maturitas 2014; 77: 73-77
28. Norton S, Chilcot J, Hunter MS,. Cognitive-behavior therapy for menopausal symptoms (hot flushes and night sweats): moderators and mediators of treatment effects. Menopause 2014; 21: 574-578
29. Barton DL, LaVasseur BI, Sloan JA, Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9. J Clin Oncol 2010; 28: 3278-3283
30. Nelson HD, Vesco KK, Haney E, Nonhormonal therapies for menopausal hot flashes: systematic review and meta-Analysis. JAMA 2006; 295: 2057-2071
31. Shams T, Firwana B, Habib F, SSRIs for hot flashes: a systematic review and meta-Analysis of randomized trials. J Gen Intern Med 2013: 1-10
32. Joy D, Joy J, Duane P,. Black cohosh: a cause of abnormal postmenopausal liver function tests. Climacteric 2008;11:84-88
33. Armitage GD, Suter E, Verhoef MJ, Bockmuehl C, Bobey M,. Women's needs for CAM information to manage menopausal symptoms. Climacteric 2007; 10: 215-224
34. Manson JE, Chlebowski RT, Stefanick ML, Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA 2013; 310: 1353-1368
35. Keenan NL, Mark S, Fugh-Berman A, Browne D, Kaczmarczyk J, Hunter C,. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies. Menopause 2003; 10: 507-515